thiazolyl blue has been researched along with Burkitt Lymphoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rath, PC | 1 |
Bennett, R; Dunn, SP; Feidler, KL; Gomez-Curet, I; Krueger, LJ; Perkins, RS | 1 |
Johnson, TA; Press, OW | 1 |
Buyukliev, R; Ivanov, D; Karaivanova, M; Konstantinov, S; Nikolova, A | 1 |
4 other study(ies) available for thiazolyl blue and Burkitt Lymphoma
Article | Year |
---|---|
Relationship between constitutive nuclear factor-kappaB (NF-kappaB) and inhibitor kappaB-alpha (IkappaB-alpha) in an interferon-alpha-sensitive human Burkitt lymphoma cell line.
Topics: Apoptosis; Blotting, Western; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Collagen Type XI; Electrophoretic Mobility Shift Assay; Humans; I-kappa B Proteins; Interferon-alpha; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53 | 2005 |
c-Myc inhibition negatively impacts lymphoma growth.
Topics: Animals; Burkitt Lymphoma; Down-Regulation; Fibroblasts; Gene Expression Profiling; Herpesvirus 4, Human; Oligonucleotide Array Sequence Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2006 |
Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Cells, Cultured | 2000 |
Preparation, physicochemical characterization and pharmacological study of novel ruthenium(III) complexes with imidazole and benzimidazole derivatives.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Burkitt Lymphoma; Cell Survival; Chemical Phenomena; Chemistry, Physical; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indicators and Reagents; Lethal Dose 50; Male; Mice; Ruthenium; Spectrophotometry, Infrared; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |